Alto Neuroscience, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Alto Neuroscience, Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, auditor ratification, and amendments to its equity incentive and employee stock purchase plans.
NYSE
Alto Neuroscience files an amendment to its proxy statement to include Inline eXtensible Business Reporting Language data tagging that was initially omitted.
NYSE
Alto Neuroscience, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 13, 2025, and provides details on accessing proxy materials and voting.
NYSE
Alto Neuroscience announces its 2025 annual meeting of stockholders to be held virtually on May 13, 2025, to vote on the election of a director and ratification of the company's independent auditor.